-
OTLK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Outlook Therapeutics (OTLK)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.70 mm | 5.70 mm | 5.70 mm | 5.70 mm | 5.70 mm | 5.70 mm |
Cash burn (monthly) | 3.07 mm | 387.84 k | 7.20 mm | 9.53 mm | 3.66 mm | 5.56 mm |
Cash used (since last report) | 5.29 mm | 667.27 k | 12.39 mm | 16.40 mm | 6.29 mm | 9.57 mm |
Cash remaining | 412.10 k | 5.04 mm | -6.69 mm | -10.69 mm | -587.15 k | -3.86 mm |
Runway (months of cash) | 0.1 | 13.0 | -0.9 | -1.1 | -0.2 | -0.7 |
13F holders | Current |
---|---|
Total holders | 72 |
Opened positions | 13 |
Closed positions | 7 |
Increased positions | 27 |
Reduced positions | 10 |
13F shares | Current |
---|---|
Total value | 42.38 bn |
Total shares | 39.57 mm |
Total puts | 11.40 k |
Total calls | 260.50 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
BioLexis Pte | 16.64 mm | $145.91 mm |
Ventures & Investments GMS | 9.27 mm | $72.14 mm |
Syntone Ventures | 2.78 mm | $23.94 mm |
Tang Capital Partners | 2.22 mm | $17.25 mm |
Tang Capital Management | 1.56 mm | $8.33 bn |
Great Point Partners | 1.29 mm | $6.90 bn |
BlackRock | 1.04 mm | $5.58 bn |
Vanguard | 855.88 k | $4.57 bn |
Velan Capital Investment Management | 750.00 k | $4.33 mm |
Altium Capital Management | 541.55 k | $2.89 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Feb 25 | Sukhtian Faisal Ghiath | Stock Option Common Stock | Grant | Acquire A | No | No | 1.825 | 12,323 | 22.49 k | 12,323 |
3 Oct 24 | Haller Julia A | Stock Option Common Stock | Grant | Acquire A | No | No | 5.25 | 12,082 | 63.43 k | 12,082 |
3 Oct 24 | Hilzinger Kurt J | Stock Option Common Stock | Grant | Acquire A | No | No | 5.25 | 18,672 | 98.03 k | 18,672 |
3 Oct 24 | Haddadin Yezan Munther | Stock Option Common Stock | Grant | Acquire A | No | No | 5.25 | 19,771 | 103.80 k | 19,771 |
1 Oct 24 | Haller Julia A | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 47,232 | 246.55 k | 47,232 |
1 Oct 24 | Haller Julia A | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 56,636 | 295.64 k | 56,636 |
1 Oct 24 | Hilzinger Kurt J | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 105,151 | 548.89 k | 105,151 |
1 Oct 24 | Hilzinger Kurt J | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 56,636 | 295.64 k | 56,636 |
1 Oct 24 | Thurman Randy H | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 89,549 | 467.45 k | 89,549 |
1 Oct 24 | Thurman Randy H | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 56,636 | 295.64 k | 56,636 |